Recent advances in inhalable liposomes for treatment of pulmonary diseases: concept to clinical stance

PP Mehta, D Ghoshal, AP Pawar, SS Kadam… - Journal of drug delivery …, 2020 - Elsevier
Liposomes and liposomes-based drug delivery systems are promising carriers in the rapidly
evolving field of nanomedicine. Liposomes are receiving growing attention in the scientific …

[HTML][HTML] Rising costs of COPD and the potential for maintenance therapy to slow the trend

CM Blanchette, NJ Gross, P Altman - American health & drug …, 2014 - ncbi.nlm.nih.gov
Background Chronic obstructive pulmonary disease (COPD) affects an estimated 14% of
adults in the United States between the ages of 40 and 79 years. This progressive disease is …

Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a …

P Altman, L Wehbe, J Dederichs, T Guerin… - BMC pulmonary …, 2018 - Springer
Background The chronic and progressive nature of chronic obstructive pulmonary disease
(COPD) requires self-administration of inhaled medication. Dry powder inhalers (DPIs) are …

In Vitro and In Silico Investigations on Drug Delivery in the Mouth-Throat Models with Handihaler®

F Huang, X Zhou, W Dai, J Yu, Z Zhou, Z Tong… - Pharmaceutical …, 2022 - Springer
This work aimed to evaluate the relative inhalation parameters that affect the deposition of
inhaled aerosols, including mouth-throat morphology, airflow rate, and initial condition of …

Controlled delivery of inhaled therapeutic agents

AJ Hickey - Journal of Controlled Release, 2014 - Elsevier
There is increasing interest in the delivery of drugs to the lungs to treat a variety of diseases.
The spatial and temporal influence of deposition and clearance mechanisms on the fate of …

Combining experimental and computational techniques to understand and improve dry powder inhalers

V Chaugule, CY Wong, K Inthavong… - Expert Opinion on …, 2022 - Taylor & Francis
ABSTRACT Introduction Dry Powder Inhalers (DPIs) continue to be developed to deliver an
expanding range of drugs to treat an ever-increasing range of medical conditions; with each …

Development of a high efficiency dry powder inhaler: effects of capsule chamber design and inhaler surface modifications

SRB Behara, DR Farkas, M Hindle… - Pharmaceutical …, 2014 - Springer
Purpose The objective of this study was to explore the performance of a high efficiency dry
powder inhaler (DPI) intended for excipient enhanced growth (EEG) aerosol delivery based …

Development and comparison of new high-efficiency dry powder inhalers for carrier-free formulations

SRB Behara, PW Longest, DR Farkas… - Journal of Pharmaceutical …, 2014 - Elsevier
High-efficiency dry powder inhalers (DPIs) were developed and tested for use with carrier-
free formulations across a range of different inhalation flow rates. Performance of a …

Characterization of dry powder inhaler performance through experimental methods

CA Ruzycki, S Tavernini, AR Martin… - Advanced Drug Delivery …, 2022 - Elsevier
Experimental methods provide means for the quality control of existing DPIs and for
exploring the influence of formulation and device parameters well in advance of clinical trials …

The effects of grid design on the performance of 3D-printed dry powder inhalers

Y Ye, Y Ma, Z Fan, J Zhu - International journal of pharmaceutics, 2022 - Elsevier
The grid structure is an indispensable part of most dry powder inhalers, but the effects of grid
geometry on inhaler performance are rarely reported. This study aims to systemically …